Skip to main content
. 2019 Oct 31;8(10):3393–3398. doi: 10.4103/jfmpc.jfmpc_482_19

Table 1.

Demographic, clinical and biochemical characteristics of the study participants

All patients COPD COPD with Metabolic syndrome P
Total patients 150 109 (72.7%) 41 (27.3%)
Males (%) 108 (72%) 78 (71.56%) 30 (73.17%) 0.845
Age (years) 58.59±7.18 57.92±7.20 60.37±6.86 0.620
Current Smokers (%) 56 (37.33%) 32 (29.33%) 24 (58.5%) 0.001
Packyears 46.03±24.21 48.31±27.75 40.00±7.31 0.712
FeV1% predicted 48.69±18.76 44.47±16.9 59.92±18.9 0.000
Waist circumference (cm) 80.48±9.78 76.75±8.35 90.39±5.38 0.000
Fasting blood sugar (mg/dL) 102.73±16.6 96.39±13.55 119.59±11.37 0.000
Triglycerides (mg/dL) 167.05±37.97 156.69±35.36 194.59±30.39 0.000
HDL (mg/dL) males 39.31±6.31 42.01±4.21 32.3±5.41 0.000
HDL females (mg/dL) 44.79±8.48 46.64±8.57 39.55±5.77 0.000
Systolic BP (mm Hg) 125.93±15.41 119.65±11.07 142.63±12.64 0.000
Diastolic BP (mm Hg) 82.63±6.92 79.66±4.81 90.54±5.28 0.000
Leucocyte count (×109/L) 8.45±1.26 8.03±0.93 9.56±1.36 0.000
hsCRP (mg/L) 4.21±0.86 3.88±0.72 5.06±0.59 0.000
Lactate (mmol/L) 2.42±0.91 2.066±0.64 3.37±0.85 0.000
Vitamin D (ng/mL) 21.47±7.99 23.22±7.79 16.8±6.58 0.000